New hope for Crohn's patients with persistent fistulas: cell therapy trial expands
NCT ID NCT07629245
First seen Jun 11, 2026 · Last updated Jun 13, 2026 · Updated 1 time
Summary
This study tests the safety of injecting a patient's own fat-derived cells into hard-to-heal anal fistulas caused by Crohn's disease. It includes up to 25 adults who did not improve in an earlier trial. The goal is to see if the treatment is safe and can help close the fistulas.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE (CD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
APHM hopital NORD
RECRUITINGMarseille, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.